C2Sense, Inc.

Truly enjoyed presenting our work to the bright fellows at the Council of Strategic Risks! #assaydevelopment, #LFA, #lateralflow, #assaytest, #diagnostics, #rapidtest, #assaymanufacturers, #pocdiagnostics

Not all lateral flow readers are created equal. Halo’s patented physics-based algorithms feature the ability to detect false positives, an issue that isn’t just a nuisance for providers and patients, but a significant factor in a manufacturer’s antibody selection. With Halo’s algorithms, you can improve your sensitivity, specificity and assay development times without worrying about non-specific binding or cross-reactivity. Contact us at contact@c2sense.com or visit www.haloreader.com for more information about this ground-breaking development. #assaydevelopment #antibodyselection #LFA #lateralflow #diagnostics #rapidtest #assaymanufacturers #pocdiagnostics

C2Sense's Chief Technology Officer, Robert Deans, Ph.D., is excited to attend ADLM and discuss our latest algorithmic advancements. To schedule a meeting with Dr. Deans and discuss how C2Sense can enhance your immunoassay performance by eliminating false positives and increasing sensitivity, please contact us at contact@c2sense.com. #ADLM #LFA #immunoassay #assay #assayperformance #assaysensitivity

C2Sense Appoints Former Chief Medical Officer of Walgreens, Dr. Kevin Ban, as Strategic Advisor to its Board of Directors “It is a pleasure to welcome Dr. Ban, with his deep experience and expertise in clinical medicine, international health, healthcare technology and population health management as an advisor to C2Sense’s Board of Directors,” said Jason Cox, Ph.D., CEO of C2Sense. “We look forward to his involvement, strategic insights and guidance as we continue the progress of our Halo® product suite.” For the full press release, visit https://lnkd.in/e8Pbk4zU For more about Halo, visit www.haloreader.com For more about Sick Health with Kevin Ban, MD, visit www.sickhealthshow.com

C2Sense welcomes Dr. Michael Mina, MD, Ph.D., Chief Scientific Officer of eMed Digital Healthcare to its Board of Directors. “We are excited to welcome Dr. Mina, an accomplished industry leader with extensive expertise in infectious diseases, molecular diagnostics and public health to C2Sense’s Board of Directors,” said Jason Cox, Ph.D., CEO of C2Sense. “Dr. Mina will provide strategic and scientific insights across many aspects of our business, including product development and commercialization, as we advance our Halo suite of customizable readers and algorithms.” To read the full release, please visit https://lnkd.in/eZetp3XS

Expanding the reach of our Halo reader into molecular testing! Combining isothermal molecular amplification (LAMP) with the simplicity of a lateral flow readout mechanism (europium or quantum dot based) yields sub-femtomole sensitivities in a model system without adding cost or complexity. Visit www.haloreader.com for more. #LFA #RapidTest #Moleculartest #LAMP #molecularamplification #assay #diagnostics #assaymanufacturer